Objective:To investigate the effect of moxifloxacin combined with piperacillin sodium and tazobactam sodium clinical effect in the treatment of severe pneumonia in;methods:in our hospital in 2012 March to 2014 January were treated 80 severe pneu-monia patients as the observation object, randomly divided into observation group and control group, 42 cases in observation group, 38 cases in the control group, two groups of patients underwent piperacillin sulbactam, control group based on the use of levofloxacin, ob-servation group with moxifloxacin, two groups were observed in patients with clinical symptoms improved time change and related in-dex;results:in the observation group, the clinical symptoms improved time was significantly lower than that of the control group, each index was significantly better than the control group, statistically significant differences (P<0.05);conclusion:in the treatment of severe pneumonia, moxifloxacin combined with piperacillin sodium and tazobactam sodium can effectively improve the symptoms of patients, reduces the treatment time, is worth to be popularized.
Severe PneumoniaPiperacillin and Sulbactam Sodium for injectionMoxifloxacin
NETL
NSTL
万方数据
